Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. DSX
2. GNK
3. INTC
4. SPCX
5. III
6. TTEC
7. DAL
8. AWK
9. TISI
10. BHP

Go back to Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns
(NASDAQ: FULC) Delayed: 3.70 +0.20 (5.71%)
Previous Close $3.50    52 Week High $ 
Open $3.56    52 Week Low $ 
Day High $3.71    P/E N/A 
Day Low $3.46    EPS $ 
Volume 6,101,106